Kelechi Chikere

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) hosted a call on Friday to divulge information about changes it made to a late-stage REGENERATE study in Nonalcoholic steatohepatitis, or NASH. Following the call, sell-side analysts gave contrasting views on the development. The Amendments The...

Wedbush believes Sangamo BioSciences, Inc. (NASDAQ: SGMO) lacks any upside potential until the year 2018, citing the pipeline gap in the face of the management’s overhauling efforts. Therefore, the firm thinks it proper to downgrade the stock from an Outperform to a Neutral rating and slashed...